title: The Cost-Effectiveness of Second-Line Crizotinib in Eml4-Alk Rearranged Advanced Non-Small Cell Lung Cancer.
authors.affiliation: St. Michael's Hospital, Toronto, ON, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Djalalov
authors.affiliation: Princess Margaret Hospital, Toronto, ON, Canada.
authors.forename: D M
authors.initials: DM
authors.lastname: Graham
authors.affiliation: St. Michael's Hospital, Toronto, ON, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Beca
authors.affiliation: Canadian Centre for Applied Research in Cancer Control (ARCC), Toronto, ON, Canada.
authors.forename: J S
authors.initials: JS
authors.lastname: Hoch
authors.affiliation: Ontario Cancer Institute, Toronto, ON, Canada.
authors.forename: M S
authors.initials: MS
authors.lastname: Tsao
authors.affiliation: Ontario Cancer Institute, Toronto, ON, Canada.
authors.forename: N
authors.initials: N
authors.lastname: Leighl